Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits
Yanaginuma, T.
Josanpu Zasshi 38(6): 526-530
1984
ISSN/ISBN: 0047-1836 PMID: 6564221 Document Number: 232050
Document emailed within 1 workday
Related Documents
Cepeláková, H.; Petrlík, M.; Cepelák, V.; Roubal, Z. 1979: Clinical pharmacology of phlebotropic drugs Folia Haematologica 106(5-6): 714-723Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33
Stanulović, M. 1989: Clinical pharmacology and the selection of drugs Medicinski Pregled 42(11-12): 391-394
Rommelspacher, H. 1991: The pharmacology of drugs (heroin, L-methadone, cocaine, hashish) and their effects on pregnancy, fetus and neonate Der Gynakologe 24(6): 315-321
Rommelspacher, H. 1991: The pharmacology of drugs (heroin, L-methadone, cocaine, hashish) and their effects on pregnancy, fetus and neonate Der Gynakologe 24(6): 315-321
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37
Von Eickstedt, K.W. 1973: Experience with phase i of clinical pharmacology in the registration of drugs Arzneimittel-Forschung 23(11 Suppl): 1677-1678
Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Farnier, M. 1992: The "duration of administration" factor in studies of clinical pharmacology of hypolipemic drugs Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 113-115
Lozinskiĭ, L.G.; Venediktova, M.G.; Zakharova, G.I.; Sandomirskiĭ, B.L. 1986: Development of methods for research on the clinical pharmacology of drugs used in cardiovascular diseases Farmakologiia i Toksikologiia 49(5): 60-62
Follath, F. 1991: Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements Journal of Cardiovascular Pharmacology 17(Suppl 6): S74-S76
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61
Takayanagi, M. 1985: Pregnancy and drugs: are all drugs harmful to the fetus? Josanpu Zasshi 39(12): 1069-1074
Stroud, R.; Cochrane, S. 1990: Midwives'. Managing without drugs Nursing Times 86(48): 70-71
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Hata, T. 2000: Drugs and pharmacology Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 115(6): 364
Bourin, M. 2006: Pharmacology of antipsychotic drugs L'Encephale 32 Pt 2: S8-S9